ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
59,298.89
1.82%
S&P 500
5,058.73
0.80%
Dow Jones
38,191.86
0.76%
US Dollar vs Yen
153.392
-1.49%
Brent Oil
83.655
0.14%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Evelo Biosciences Inc (EVLO)

  7. Evelo Biosciences Inc (EVLO) ニュース

EVLO Evelo Biosciences Inc

0.3165
0.00 (0.00%)
最終更新日： 09:00:00
15分遅延
名称 銘柄コード 市場 種別
Evelo Biosciences Inc EVLO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 0.3165 09:00:00
始値 安値 高値 終値 前日終値
0.3165
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/1/2707:30EDGAR2Form 15-12G - Securities registration termination [Section..
2024/1/2707:29EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/1/2707:27EDGAR2Form POS AM - Post-Effective amendments for registration..
2024/1/2707:26EDGAR2Form 8-K - Current report
2023/12/1221:43EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/1221:42EDGAR2Form DEF 14A - Other definitive proxy statements
2023/12/0420:04EDGAR2Form 8-K - Current report
2023/12/0121:11EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/11/2120:44EDGAR2Form 8-K - Current report
2023/11/1007:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0910:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0910:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0910:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0405:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0405:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0405:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2806:24EDGAR2Form 8-K - Current report
2023/10/1720:05EDGAR2Form 8-K - Current report
2023/10/1720:00GLOBEEvelo Biosciences Announces Top-Line Results From its Phase..
2023/9/1409:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1409:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1409:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2206:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/2120:43EDGAR2Form 8-K - Current report
2023/8/1813:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/1421:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1420:42EDGAR2Form 8-K - Current report
2023/8/1420:30GLOBEEvelo Biosciences Announces Second Quarter Financial Results..
2023/8/1105:02EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/1009:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1009:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1009:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/2105:21EDGAR2Form 8-K - Current report
2023/7/1820:27IHMARKETNEWSTuesday’s Wall Street Highlights: Novartis, BofA, Dollar..
2023/7/1305:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1305:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/7/1220:55EDGAR2Form 8-K - Current report
2023/7/1220:30GLOBEEvelo Biosciences Closes $25.5 Million Private Placement
2023/7/1020:36EDGAR2Form 8-K - Current report
2023/7/1020:30GLOBEEvelo Biosciences Announces $25.5 Million Private Placement
2023/7/0805:06EDGAR2Form 8-K - Current report
2023/6/3006:10EDGAR2Form 8-K - Current report
2023/6/2922:00GLOBEEvelo Biosciences Announces Reverse Stock Split Effective
2023/5/1619:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..

最近閲覧した銘柄

NASDAQ
EVLO
Evelo Biosciences
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有